Liraglutide
The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
Novo Nordisk · Phase 2 · Completed · Enrollment 564
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Lira placebo/Lira 2.4 mg/Lira 3.0 mg | 29 participants | 6 participants | 20 participants | n/r | n/r |
| Lira 1.2 mg/Lira 3.0 mg | 35 participants | 12 participants | 15 participants | n/r | n/r |
| Lira 1.8 mg/Lira 3.0 mg | 34 participants | 13 participants | 16 participants | n/r | n/r |
| Lira 2.4 mg/Lira 3.0 mg | n/r | n/r | n/r | n/r | n/r |
| Liraglutide 3.0 mg | 47 participants | 13 participants | 18 participants | n/r | n/r |
| Orlistat | 8 participants | 0 participants | 33 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.